Thyroid Cancer

 

E7080 for 131I-Refractory Differentiated Thyroid Cancer (UW11023)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of E7080 in 131I-Refractory Differentiated Thyroid Cancer

Investigator: Renato G. Martins, MD;   Conditions: Thyroid Cancer;    Status: Recruiting;   Study ID: NCT01321554

Pazopanib in Combination w/ Radioactive 131I (7529)
A Phase I Clinical Trial of Pazopanib in Combination with Escalating Doses of Radioactive 131I in Patients with Well-Differentiated Thyroid Carcinoma Refractory to Radioiodine, Despite Having Some Uptake

Investigator: Laura Chow;   Conditions: Thyroid Cancer;    Status: Recruiting;   Study ID: NCT01413113